Navigation Links
Reliv’s LunaRich Earns Ingredient Patent

Chesterfield, MO (PRWEB) August 08, 2013

Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that LunaRich® has earned a new patent from the US Patent and Trademark Office. The composition of matter patent protects the LunaRich technology as it relates to its superior ability to deliver bioactive lunasin to the body. Lunasin is a naturally occurring peptide scientists have identified as the key to many of soy’s documented health benefits.

“This is an exciting step forward for Reliv and for our LunaRich product line,” said Dr. Carl W. Hastings, Reliv vice chairman and chief scientific officer. “We already owned a patent for LunaRich’s ability to reduce LDL cholesterol. Now we have added a patent for the LunaRich material itself. The result is a very strong patent portfolio for a remarkable nutritional ingredient.”

The patent announcement comes only two weeks after Reliv entered into an exclusive license for the intellectual property of Soy Labs LLC related to the nutritional ingredient lunasin. The license covers a previously issued patent and several patent applications (one now granted) related to lunasin and soy-related peptides, proprietary information and manufacturing processes.

LunaRich’s Superior Bioavailability

The amount of lunasin in soybeans varies significantly based on seed, soil and environment. LunaRich uses specially selected soybeans grown exclusively for Reliv with highly concentrated levels of bioactive lunasin.

LunaRich’s unique refinement process retains a more uniform and integrated “shell” of protease inhibitors, which serve as protective chaperone molecules to better protect the lunasin from being destroyed in the stomach. The shell is then broken down to allow for maximum absorption of lunasin in the small intestine, where it can provide the greatest benefit. Learn more about LunaRich's bioavailability.

“We have demonstrated through our exclusive bioassay, based on lunasin's proprietary epigenetic mechanism of action, that LunaRich products maintain lunasin’s bioactivity after digestion,” said Dr. Alfredo Galvez, lead scientific advisor at SL Technologies, a Reliv subsidiary. “It is the only test of its kind in the supplement industry and gives Reliv the unique ability to guarantee the bioavailability of lunasin in its LunaRich products. Now we have a patent to protect the novel formulations that make LunaRich products so effective in providing all the health benefits of lunasin." Learn more about the benefits of lunasin.

How Lunasin Works

Lunasin is one of the first nutritional compounds identified to affect gene expression and promote optimal health at the epigenetic level. The epigenome, which literally means “beyond the genome,” is a higher level of complexity within the cell. It acts like a dimmer for lights, controlling which genes are used, when they are used and how much they are used.

Lunasin can attach itself to the epigenome. As a result, it can increase expression of important genes needed for normal cell functioning and protect the cells from environmental damage once it occurs. More than 50 published papers from more than 25 research institutions demonstrate lunasin’s multiple health benefits. Learn more about lunasin and epigenetics.

In addition to the LunaRich patents, nine Reliv nutritional formulas have earned US patents: Reliv Classic® for essential daily nutrition, Innergize!® for isotonic hydration, FibRestore® for digestive health, Cellebrate® for weight loss, Arthaffect® for joint health, ReversAge® for anti-aging, GlucAffect® for blood sugar management, ProVantage® for performance nutrition and 24K™ for healthy energy. Note: the patents for Reliv Classic and Innergize! have expired.

About Reliv International, Inc.

Reliv International, based in Chesterfield, Mo., produces nutritional supplements that promote optimal nutrition along with premium skincare products. Reliv supplements address essential nutrition, weight loss, athletic performance, digestive health, women's health, anti-aging and healthy energy. Reliv is the exclusive provider of LunaRich® products, which optimize levels of lunasin, the peptide behind many of soy’s health benefits. The company sells its products through an international network marketing system of independent distributors in 16 countries. Learn more about Reliv at, or on Facebook, Twitter or YouTube.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Reliv’s LunaRich X Named Finalist for 2013 American Business Awards
2. Louisiana Tech University professor earns NSF Early Career Development grant
3. Cedars-Sinai stroke team earns award for improving regions quality of care
4. Louisiana Tech biomedical engineering professor earns recognition, funding for research
5. Macho Men Do Worse in Couples When the Woman Earns More
6. Kolanowski earns GSAs 2012 Doris Schwartz Gerontological Nursing Research Award
7. Hoppmann earns GSAs 2012 Baltes Foundation Award
8. Beck earns GSAs 2012 M. Powell Lawton Award
9. Naylor earns GSAs 2012 Maxwell A. Pollack Award for Productive Aging
10. Crimmins earns GSAs 2012 Robert W. Kleemeier Award
11. University of Colorado Cancer Center earns major grant to develop new bladder cancer drugs
Post Your Comments:
(Date:11/28/2015)... PITTSBURGH, PA (PRWEB) , ... November 28, 2015 , ... ... Manalapan, N.J., has created the COUCH BUDDY. "I conceived of this design due to ... more comfort for couch users. It promotes relaxation and convenience, as well as increases ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... conversation at the recent 2015 American Dental Association meeting in Washington D.C. revolved around ... help protect a patient’s overall health. The talk stressed the link between periodontal disease ...
(Date:11/27/2015)... Raleigh, NC (PRWEB) , ... November 27, 2015 , ... ... most effective ways to treat it. Surviving Mesothelioma has just posted the findings ... Researchers at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component of ... in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of approximately ... nationally, through a vast social media strategy and across a network of top ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec ... Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users ... Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... ) ... "2016 Global Tumor Marker Testing Market: Supplier ... Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive ... offering. --> ) has ... Global Tumor Marker Testing Market: Supplier Shares ...
(Date:11/26/2015)... --> --> ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy can be efficiently combined with photodynamic therapy (PDT) ...
(Date:11/26/2015)... , November 26, 2015 3D ... by 2022, according to a new report by Grand View ... Kidney Disease (CKD) which demands kidney transplantation is expected to ... cost effective substitute for organ transplantation. --> 3D ... by 2022, according to a new report by Grand View ...
Breaking Medicine Technology: